Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 2/3 2Phase NA 1Phase 1/2 1

Status

Completed 4Terminated 3Unknown 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 2Smoldering Multiple Myeloma 1Peripheral Nervous System Diseases 1Monoclonal Gammopathy of Undetermined Significance 1Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Cyclophosphamide 166Docetaxel 154Bevacizumab 153Carboplatin 148Gemcitabine 146Cisplatin 146pembrolizumab 144Radiotherapy 135Paclitaxel 132Capecitabine 122Rituximab 115Oxaliplatin 104Fluorouracil 103Nivolumab 94Irinotecan 85Doxorubicin 85Pemetrexed 83Leucovorin 82Dexamethasone 82fludarabine 74fludarabine phosphate 72Bortezomib 69Etoposide 67Erlotinib Hydrochloride 66Cetuximab 65Methotrexate 58Trastuzumab 56Cytarabine 54Lenalidomide 50Everolimus 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Terminated × Fatty Acids, Omega-3 × Clear all
NCT02795572 2019-07-05

CIPN

AHS Cancer Control Alberta

Phase 2 Terminated
13 enrolled
Breast

Breast Neoplasms, Peripheral Nervous System Diseases

NCT00930527 2014-07-23

Omega-3-Fatty Acid on Joint Symptoms Inducted by Aromatase Inhibitors

Columbia University

Phase 2 Terminated
10 enrolled
Breast

Breast Neoplasms

NCT00899353 2013-12-12

Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM)

Marshall University

Phase 2 Terminated
16 enrolled 6 charts
LymphoidOther hematologic neoplasmPlasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡